Alerus Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Alerus Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2K	Buy	+31	New	+$2.08K	﹤0.01%	194

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alerus Investment Advisors's DGX Position: Q1 2016 in Review

Alerus Investment Advisors opened a new position in Quest Diagnostics (DGX) in Q1 2016: 31 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #194 among its holdings.

557 funds tracked by Wall St. Rank hold DGX as of Q1 2016.

Alerus Investment Advisors held 31 shares of Quest Diagnostics worth $2K as of Q1 2016.
Quest Diagnostics was a new Alerus Investment Advisors position in Q1 2016.
Quest Diagnostics made up ﹤0.01% of Alerus Investment Advisors's portfolio in Q1 2016, its #194 holding.
557 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.